Radar Healthcare buys New Zealand's Cemplicity to expand patient insight tools
What's the deal? Leeds-based Radar Healthcare Group has acquired CemplicityDealroom has a profile for this one. Try Dealroom →, a New Zealand-headquartered patient experience and patient-reported outcomes platform. Terms were not disclosed.
Who's who? Radar Healthcare supports health and care organisations with quality, risk, compliance, incident, audit and action management analytics, plus patient information and digital consent. Cemplicity adds patient-reported experience measures (PREMs), patient-reported outcome measures (PROMs), real-time feedback and post-care outcomes.
Cemplicity runs its southern hemisphere operations and R&D in New Zealand, with northern hemisphere operations in London.
What's the endgame? The deal builds on Radar Healthcare's acquisition of digital consent and patient information specialist EIDO HealthcareDealroom has a profile for this one. Try Dealroom →. It extends the company's reach across quality, safety, patient engagement, informed consent and measurable improvement.
Why it matters: "Together, we can help customers connect what patients are experiencing with the workflows needed to act on that insight and drive meaningful improvement," said Edward Bellamy, chief executive at Radar Healthcare.
Cemplicity's Blaik Wilson said joining Radar Healthcare "gives us an exciting opportunity to build on that work, extend our impact and support more organisations in using patient-reported insight to improve care."
Radar Healthcare is backed by Marlin Equity PartnersDealroom has a profile for this one. Try Dealroom →, which is providing support as the business invests in its platform, people and customer success capabilities.
The signal: The acquisition marks Radar Healthcare's second deal in August 2026, pointing to a private equity-fuelled push to consolidate healthtech capabilities across the quality, safety and patient experience stack.
Read more: Insider Media
Image credit: juhansonin
